Vaxcyte PCVX
NASDAQ PCVX
$68.62 +2.26 (+3.41%)
At close: Nov 11, 2026 · 4:00 PM EST

Vaxcyte (PCVX) Long-Term Debt Repayments (2019 - 2020)

Updated

Vaxcyte's Long-Term Debt Repayments came in at $61,000 for FY2020, down 78.1% from $278,000 in FY2019.

Analysis

Vaxcyte (PCVX) Long-Term Debt Repayments (2019 - 2020) Analysis & Trends

  • Per Business Quant, earlier years put Long-Term Debt Repayments at $278,000 in FY2019 (-1.8%) and $283,000 in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 1.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -4.91 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 3.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 19.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Vaxcyte 9.91 Bn 3.83 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 1,000.00
Mar 31, 2020 60,000.00
Dec 31, 2019 58,000.00
Sep 30, 2019 65,000.00
API Access

Vaxcyte Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=PCVX&period=max&api_key=YOUR_API_KEY